Pharmafile Logo

20:20 Selection Ltd

We are 20:20 Selection. Over more than 10 years we have built our reputation in providing unrivalled professional medical recruitment services to both our clients and candidates. During that time we have placed over 1000 candidates into positions throughout the UK and Ireland. The 20:20 Selection Ltd team has over 50 years of experience which is relevant and specific to the pharmaceutical and healthcare jobs sector. Our experienced, professional team will guide you through the process of assessing which is the ideal medical sales job for you. From helping you prepare a compelling CV, to researching and deciding which Medical Sales vacancies would be right for you.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

M3 (EU)

M3 has over 20 years’ experience in building online doctor communities. M3 is the world’s largest network of verified doctors with over 6 million members across M3-owned networks and an…

View Profile

Company Details

6-8 Towngate Works, Dark Lane, Mawdesley, Lancashire, L40 2QU, United Kingdom
+44 (0)845 026 2020

 Latest Content from PMHub 

IBD Oxford MasterClass 2016 harnesses the chemistry between science and clinical practice

Leading Edge, part of the Lucid Group, delivered another successful Oxford MasterClass this year, which attracted over 260 delegates and 60 international inflammatory bowel disease (IBD) faculty, representing Europe, Asia, Australasia...

Artificial Intelligence: the new healthcare algorithm

The age of computers has hugely evolved, and with the emergence of effective machine learning, pattern recognition, and decision-making algorithms, Artificial Intelligence provides a revolutionary new approach to tailored healthcare....

Lucid Group becomes a sponsor of MedComms Networking

To help Lucid access the valuable medical communications professional network they have become a sponsor of MedComms Networking, headed by Peter Llewellyn. Jan Steele (Co-founder and COO of Lucid Group)...

Showcasing our multichannel capabilities in Berlin

Join Anthill for conferences in October to understand how to bring value to HCPs through multichannel communications

DAM and CMS: managing assets to maximise adoption and value

Senior Account Executive Dave Wood talks us through what DAM and CMS are, the role they play in the future of healthcare marketing, and how they can be best utilised...

Lucid launch new recruitment campaign to attract top talent in medical writing

We will offer talented writers an exclusive, tailor-made package to suit their individual needs and desires. We want you to define the framework of your Lucid Life contract – from...

Knowing your audience is key to successful medical education

Lucid Group understands that the goals of medical education are to disseminate best practice and advance patient outcomes. Our approach to meeting these goals centres on our appreciation of both...

How to enable each healthcare professional to fully understand your product

Read these three articles to understand how working at an individual level benefits all customers:

Alzheimer’s disease: reviewing the immediate treatment horizon

Account Manager Stuart Goodman takes a look at some of the promising categories of Phase 3 treatments that could soon be available to patients with Alzheimer's disease.